METALLOENZYME INHIBITOR COMPOUNDS,申请号WO2012US43147-传众专利搜索

首页产品黄页商标征信

会员服务注册登录

法人/股东/高管

发明名称	METALLOENZYME INHIBITOR COMPOUNDS
摘要	The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
申请公布号	WO2012177638(A1)	申请公布日期	2012.12.27
申请号	WO2012US43147	申请日期	2012.06.19
申请人	VIAMET PHARMACEUTICALS, INC.;HOEKSTRA, WILLIAM, J.;YATES, CHRISTOPHER, M.;SCHOTZINGER, ROBERT, J.;LOSO, MICHAEL;BUCHAN, ZACHARY, A.;SULLENBERGER, MICHAEL	发明人	HOEKSTRA, WILLIAM, J.;YATES, CHRISTOPHER, M.;SCHOTZINGER, ROBERT, J.;LOSO, MICHAEL;BUCHAN, ZACHARY, A.;SULLENBERGER, MICHAEL
分类号	C07D401/06;A01N43/34;A01N43/713;A01P3/00;C07D401/14	主分类号	C07D401/06
代理机构		代理人
主权项
地址

您可能感兴趣的专利

CATHETER ASSEMBLY

NASAL CANNULA ASSEMBLY WITH INHALATION VALVES COMMUNICATING WITH A DEFORMABLE RESERVOIR

POSITIONING DEVICE AND METHOD FOR USE WITH A PATIENT UNDER ANESTHESIA

Guiding Device for Dental Anesthesia

DRUG DELIVERY SYSTEM AND METHOD FOR CONTROLLED AND CONTINUOUS DELIVERY OF DRUGS INTO THE BRAIN BY BYPASSING THE BLOOD BRAIN BARRIER.

Five-Port Blood Separation Chamber And Methods Of Using The Same

COMPOSITIONS AND METHODS FOR SURFACE MINERALIZATION

PHARMACEUTICAL COMPOSITION WITH IMPROVED STORAGE STABILITY AND METHOD FOR PREPARING THE SAME

HERPES SIMPLEX VIRUS VACCINES

Peptide Sequences and Compositions

COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

METAP2 INHIBITORS AND METHODS OF TREATING OBESITY

Purified Extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma

USE OF LACTOBACILLUS RHAMNOSUS FOR PROMOTING RECOVERY OF THE INTESTINAL MICROBIOTA DIVERSITY AFTER DYSBIOSIS

METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS

ASSOCIATION BETWEEN 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL)ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-g][1,2,3]BENZOTRIAZINE-4,9-DIONE AND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

METHOD FOR TREATING CANCER

mTORC1 MODULATION BY AMINO ACIDS AND USES THEREOF

Aqueous Composition for Ophthalmological Use or Otolaryngological Use